Isomorphic Labs, a Google-backed AI company, is set to begin human trials for cancer drugs designed by AI, raising both hope ...

The "acqui-hire" strategy is on fire in this battle among tech titans seeking AI dominance and a Goliath just beat David ...

Chicago, IL – July 17, 2025– Today, Zacks Investment Ideas feature highlights Alphabet GOOGL, Meta Platforms META, Tesla TSLA ...

Tech giants like Meta and Google have been making huge investments and poaching talent from AI startups like ScaleAI and ...

Traditionally, drug discovery relied heavily on trial and error, with long timelines and high costs. The introduction of ...

At ICML, the AI research elite gather to present papers, chase jobs, and quietly shape the future of the field.

AI models have just taken a startling step toward autonomy. In a shocking experiment, OpenAI’s o3 model rewrote its own code ...

Seven biotech unicorns are advancing AI-powered drug discovery and development—but must contend with a difficult investing ...

Below are the most-read DIGITIMES Asia stories from July 7 to July 13, 2025. This week's top three highlights include China’s ...

Despite hefty investment into AI, Microsoft is struggling to make headway against ChatGPT and a host of other AI assistants.

Glenmark’s progress with a cancer treatment shows the potential of Indian pharma to move from generics to drug discovery. With tech-enabled therapies evolving fast, new inflection points spell a ...

Google’s AI agent, dubbed Big Sleep, has achieved a cybersecurity milestone by detecting and blocking an imminent exploit in ...